Back to search results

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

IsraelRecruitingPHASE3

Conditions

Sickle Cell Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Alabama at Birmingham- Site Number : 8400003, Birmingham, Alabama, United States

  • Phoenix Children's Hospital- Site Number : 8400028, Phoenix, Arizona, United States

  • University of California San Francisco- Site Number : 8400040, Fresno, California, United States

  • Oncology & Hematology Associates of West Broward- Site Number : 8400029, Coral Springs, Florida, United States

  • Sylvester Comprehensive Cancer Center- Site Number : 8400020, Miami, Florida, United States

  • University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago, Illinois, United States

  • Indiana University Health Riley Hospital for Children- Site Number : 8400056, Indianapolis, Indiana, United States

  • Louisiana State University Health Sciences Center - Shreveport- Site Number : 8400037, Shreveport, Louisiana, United States

  • University of Maryland School of Medicine - Baltimore- Site Number : 8400041, Baltimore, Maryland, United States

  • University of Michigan Health System - Ann Arbor- Site Number : 8400035, Ann Arbor, Michigan, United States

  • Southern Specialty Research- Site Number : 8400059, Flowood, Mississippi, United States

  • Richmond University Medical Center- Site Number : 8400038, Staten Island, New York, United States

  • Montefiore Medical Center - Moses Campus- Site Number : 8400057, The Bronx, New York, United States

  • Prisma Health- Site Number : 8400051, Greenville, South Carolina, United States

  • Baylor College of Medicine- Site Number : 8400055, Houston, Texas, United States

  • VCU Massey Cancer Center: Dalton Oncology Clinic- Site Number : 8400012, Richmond, Virginia, United States

  • Investigational Site Number : 0560003, Brussels, Belgium

  • Investigational Site Number : 0560002, Brussels, Belgium

  • Investigational Site Number : 0560001, Leuven, Belgium

  • Hospital Santa Izabel- Site Number : 0760006, Salvador, Estado de Bahia, Brazil

  • Universidade Federal de Goias- Site Number : 0760002, Goiânia, Goiás, Brazil

  • Fundação Faculdade Regional de Medicina de São José do Rio Preto- Site Number : 0760001, São José do Rio Preto, São Paulo, Brazil

  • Pontifícia Universidade Católica do Rio de Janeiro- Site Number : 0760009, Rio de Janeiro, Brazil

  • Hospital Samaritano De Sao Paulo- Site Number : 0760005, São Paulo, Brazil

  • Investigational Site Number : 2500002, Créteil, France

  • Investigational Site Number : 2500005, Marseille, France

  • Investigational Site Number : 2500001, Paris, France

  • Investigational Site Number : 2500004, Toulouse, France

  • Investigational Site Number : 2760002, Essen, Germany

  • Investigational Site Number : 2760004, Stuttgart, Germany

  • Investigational Site Number : 3000001, Athens, Greece

  • Investigational Site Number : 3000003, Athens, Greece

  • Investigational Site Number : 3000002, Pátrai, Greece

  • Investigational Site Number : 3760001, Afula, Israel

  • Investigational Site Number : 3760002, Afula, Israel

  • Investigational Site Number : 3760005, Haifa, Israel

  • Investigational Site Number : 3760006, Haifa, Israel

  • Azienda Ospedaliero Universitaria Careggi SOD Ematologia-Site Number : 3800006, Florence, Firenze, Italy

    Contact: Study coordinator (Valentina Carrai) · carraiv@aou-careggi.toscana · 055 7949777
    Contact: Study coordinator (Silvia Querceto) · silvia.querceto@unifi.it · 055 7949777
    Contact: Principal Investigator (Valentina Carrai)

  • Investigational Site Number : 3800004, Milan, Milano, Italy

  • Azienda Ospedaliera Universitaria, Università della Campania "Luigi Vanvitelli" Napoli-Site Number : 3800005, Naples, Napoli, Italy

    Contact: Study coordinator (Silverio Perrotta) · silverio.perrotta@unicampania.it · +390815664185
    Contact: Study coordinator (Laura Pinfildi) · pinfildilaura@gmail.com · +390815664185
    Contact: Principal Investigator (Silverio Perrotta)

  • IRCCS Ospedale Pediatrico Bambino Gesù-Site Number : 3800001, Rome, Roma, Italy

    Contact: Study coordinator (Centro Trial Oncoematologico) · centrotrial-oncoematologico@opbg.net · +390668593697
    Contact: Principal Investigator (Franco Locatelli)

  • Azienda Ospedaliera Universitaria San Luigi Gonzaga, SSD Microcitemie Malattie Rare Ematologiche-Site Number : 3800007, Orbassano, Torino, Italy

    Contact: Study coordinator (Rosa Maria Catena De Maria) · rosamaria.demaria@unito.it · +393398110707
    Contact: Study coordinator (Vincenzo Voi) · vincenzo.voi@unito.it · +390119026852
    Contact: Principal Investigator (Vincenzo Voi)

  • Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello-Site Number : 3800002, Palermo, Italy

    Contact: Study coordinator (Rosario Di Maggio) · rdm83@hotmail.it · +390917802034
    Contact: Study coordinator (Alessandro Inzerillo) · aleinzerillo22@gmail.com · +393277653510
    Contact: Principal Investigator (Rosario Di Maggio)

  • Centro Ricerche Cliniche Verona s.r.l. presso Ospedale G.B. Rossi Borgo Roma-Site Number : 3800003, Verona, Italy

    Contact: Study coordinator (Lucia De Franceschi) · filippo.mazzi@aovr.veneto.it · +390458124918
    Contact: Principal Investigator (Lucia De Franceschi)

  • Investigational Site Number : 5280002, Rotterdam, Netherlands

  • Investigational Site Number : 5120001, Muscat, Oman

  • Investigational Site Number : 7240002, Madrid, Spain

  • Investigational Site Number : 7240001, Madrid, Spain

  • Investigational Site Number : 7920001, Adana, Turkey (Türkiye)

  • Investigational Site Number : 7920002, Adana, Turkey (Türkiye)

  • Investigational Site Number : 7920003, Mersin, Turkey (Türkiye)

  • Investigational Site Number : 8260002, London, Harrow, United Kingdom

  • Investigational Site Number : 8260001, London, London, City of, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)